They Got Estimates Before Surgery — And A Bill After That Was 50% More
Patients are often told to be smart consumers and shop around for health care before they use it. What happens when people actually take that advice?
Search
Filter
5,821 - 5,840 of 15,225 Results
-
-
Shopping At The Apotheke: Compare German Pharmacies With Your Corner Drugstore
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
-
‘Locally Grown’ Insurance Companies Help Fortify Washington State Market
The individual insurance market in Washington is dominated by companies that do business only in the Pacific Northwest, and the state’s insurance commissioner credits them with helping keep premium rates lower than in other states.
-
Governor’s ‘Mental Health Czar’ Seeks New Blueprint For Care In California
Thomas Insel, who ran the National Institute of Mental Health for 13 years before casting his lot with Silicon Valley, is taking a temporary break from his senior position at a health care startup to advise Gov. Gavin Newsom on how to remake mental health care in the Golden State.
By Rob Waters -
In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
By Sarah Varney -
Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
By Sarah Varney -
In Rural Utah, Preventing Suicide Means Meeting Gun Owners Where They Are
In Utah, 85% of deaths from firearms are suicides. To help people who might be vulnerable, outreach workers are discussing suicide prevention at gun shows and firearms classes.
-
Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases.
-
Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
-
How And When Immigrants’ Use Of Government Benefits Might Affect Their Legal Status
Confusion about a new federal rule to restrict legal immigration based on the use of public benefits may dampen sign-ups for health care, housing and food aid even among immigrants not directly targeted by the rule. Here are some answers to frequently asked questions that will help clear up some of the misunderstanding.
-
Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
-
Coming Out About Mental Health On Social Media
Talking about your mental health on social media is a thing, and it could actually help.
-
Why Red Wyoming Seeks The Regulatory Approach To Air Ambulance Costs
Wyoming is taking on expensive air ambulance bills by trying to expand Medicaid to cover transport for all patients. This is a big change: a red state seeking to control what's been a growing free-market bonanza.
-
Doctors Fight Legislation Prompted By Sex Abuse Scandals
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
-
Years Ago, This Doctor Linked A Mysterious Lung Disease To Vaping
In an exclusive interview, a West Virginia physician says that back in 2015 he had a sense a patient’s illness “probably wasn't the first case ever seen nor would it be the last.” Was it a sentinel event?
-
Readers And Tweeters Take Dialysis Providers To Task: Nowhere But In The USA
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Picture Of Health
Dialysis Industry Spends Big To Protect Profits
Dialysis companies are fighting a bill in the California legislature that could disrupt their business model. Their weapons: campaign cash and a sophisticated public relations campaign.
-
KHN’s ‘What The Health?’: All About Medicare
Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.